Additionally, several studies have shown that MYC hyperactivation, a common feature in many human cancers, leads to transcriptional upregulation of splicing factors that direct breast cancer-associated AS switches promoting a malignant phenotype [10–12]. This evidence concerns the gene MYC and breast cancer.